Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Cardiomyopathy-hypotonia-lactic acidosis syndrome is characterized by hypertrophic cardiomyopathy, muscular hypotonia and the presence of lactic acidosis at birth. It has been described in two sisters (both of whom died within the first year of life) from a nonconsanguineous Turkish family. The syndrome is caused by a homozygous point mutation in the exon 3A of the SLC25A3 gene encoding a mitochondrial membrane transporter.
Features include very common findings: Thickened heart muscle (hypertrophic cardiomyopathy), Low muscle tone (hypotonia), Metabolic acidosis, and Lactic acidosis and others; and common findings: Cyanosis, Failure to thrive, Myopathy, and Low-output congestive heart failure. 13 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Heart and blood vessels | 2 | Thickened heart muscle (hypertrophic cardiomyopathy), Low-output congestive heart failure |
SLC25A3 function has not been fully characterized.
Cardiomyopathy-hypotonia-lactic acidosis syndrome is associated with mutations in the SLC25A3 gene on chromosome 12.
Genetic testing for SLC25A3 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for cardiomyopathy-hypotonia-lactic acidosis syndrome has been reported in the published literature.
Phenotype severity distribution: 6 very common features, 4 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for cardiomyopathy-hypotonia-lactic acidosis syndrome.
205 publications have been identified in PubMed for cardiomyopathy-hypotonia-lactic acidosis syndrome. Research spans Case Report / Case Series (39%), Review / Meta-Analysis (32%), and Epidemiology / Natural History (13%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 66 | 39% |
Data assembled from 6 of 12 sources · Last updated Sep 20, 2026, 5:41 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Muscles | 2 | Low muscle tone (hypotonia), Myopathy |
Lungs and breathing | 2 | Difficulty breathing (respiratory insufficiency), Respiratory distress |
Metabolism | 1 | Metabolic acidosis |
Lab test results | 1 | Increased circulating lactate concentration |
Growth and development | 1 | Failure to thrive |
Research summaries |
55 |
32% |
Disease patterns and progression | 22 | 13% |
Laboratory research | 13 | 8% |
Clinical study results | 6 | 4% |
Testing and diagnosis research | 5 | 3% |
New treatment approaches | 3 | 2% |
Lovegrove SS (2026). [PMID: 41656027](https://pubmed.ncbi.nlm.nih.gov/41656027/). *Endocrinology and metabolism clinics of North America*. [Review / Meta-Analysis]
Dubakula VV (2026). [PMID: 42223382](https://pubmed.ncbi.nlm.nih.gov/42223382/). *Proc (Bayl Univ Med Cent)*. [Review / Meta-Analysis]
Combes A (2026). [PMID: 41495763](https://pubmed.ncbi.nlm.nih.gov/41495763/). *Crit Care*. [Clinical Trial Publication]
Akyüzlüer Güneş MS (2026). [PMID: 42232680](https://pubmed.ncbi.nlm.nih.gov/42232680/). *Mol Syndromol*. [Case Report / Case Series]
Garfield K (2026). [PMID: 29262095](https://pubmed.ncbi.nlm.nih.gov/29262095/). *Unknown Journal*. [Epidemiology / Natural History]
Wynkoop HJ (2026). [PMID: 41935286](https://pubmed.ncbi.nlm.nih.gov/41935286/). *Malar J*. [Epidemiology / Natural History]
Hennings JC (2026). [PMID: 41671337](https://pubmed.ncbi.nlm.nih.gov/41671337/). *Science translational medicine*. [Basic Science / Preclinical]
Zerrouki S (2026). [PMID: 42069983](https://pubmed.ncbi.nlm.nih.gov/42069983/). *Pediatr Nephrol*. [Review / Meta-Analysis]
Krishnamurthy S (2026). [PMID: 41741919](https://pubmed.ncbi.nlm.nih.gov/41741919/). *Indian journal of pediatrics*. [Review / Meta-Analysis]
Eser AK (2026). [PMID: 41994667](https://pubmed.ncbi.nlm.nih.gov/41994667/). *Cureus*. [Case Report / Case Series]